Initiss Plus

Cilazapril and Hydrochlorothiazide, the active ingredients in Initiss Plus, are an ACE inhibitor and thiazide diuretic combination presented as an oral tablet for adult use. It treats hypertension by lowering blood pressure in patients who require combined therapy.

GNH USA supplies Initiss Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Initiss Plus is used to manage high blood pressure within the antihypertensive drug class.

- Essential hypertension: lowers systolic and diastolic pressure in patients with primary hypertension. - Secondary hypertension: assists in blood‑pressure control when hypertension is caused by another condition. - Hypertension with fluid retention: reduces blood volume and pressure in patients who also have edema.

Common Side Effects: - Dizziness or light‑headedness. - Persistent dry cough. - Headache. - Fatigue or weakness. - Increased urination. - Mild electrolyte disturbances (e.g., low potassium).

Serious or Rare Side Effects: - Angioedema or swelling of the face, lips, tongue, or throat. - Severe dehydration or electrolyte imbalance. - Hyperkalemia (high potassium levels). - Acute kidney injury or worsening renal function. - Marked hypotension leading to fainting. - Blood dyscrasias such as agranulocytosis.

Before initiating therapy, clinicians should assess renal function, electrolyte status, and overall cardiovascular risk.

- Renal monitoring: check serum creatinine and eGFR regularly. - Electrolyte monitoring: watch for potassium and sodium changes. - Avoid in severe renal impairment: dose adjustment may be required. - Caution in patients with gout: thiazide component can raise uric acid. - Pregnancy and lactation: safety not established; use only if clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Initiss Plus may interact with several drug classes; monitoring is essential.

Major Interactions (Avoid): - Aliskiren: combined use can cause excessive potassium rise and renal dysfunction. - Potassium‑sparing diuretics or supplements: increase risk of hyperkalemia. - Lithium: ACE inhibition may raise lithium levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect and impair renal function. - Other antihypertensives (beta‑blockers, calcium channel blockers): may cause additive blood‑pressure lowering. - Digoxin: thiazide component can increase digoxin concentrations. - Antidiabetic agents: diuretic‑induced changes in glucose may require dose adjustment.